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Biosciences, ETH Zürich, CH-8093 Zürich, Switzerland 
 
Continuous manufacturing is currently being considered by the Biopharmaceutical 
Industry not only for the classical reasons which make continuous operation preferred 
over the batch one, but also for recent initiatives of the regulatory agencies. We discuss 
here a series of experiments where a perfusion reactor with CHO cells for the production 
of a monoclonal antibody has been operated in the continuous mode and connected to a 
two column continuous protein A chromatographic unit for product capture. A few steady 
states are examined and the use of simulation models for process design and control is 
illustrated. 
